Integrins Bidirectional, Allosteric Signaling Machines by Hynes, Richard O.
Cell, Vol. 110, 673–687, September 20, 2002, Copyright 2002 by Cell Press
ReviewIntegrins: Bidirectional,
Allosteric Signaling Machines
and Hynes, 2002). The simplest metazoa, sponges and
cnidaria, have integrins (Burke, 1999; Hughes, 2001) and
it is clear that primitive bilateria had at least two integrin
Richard O. Hynes1
Howard Hughes Medical Institute
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Department of Biology  heterodimers, the descendents of which persist to
this day in organisms as diverse as flies, nematodes,Massachusetts Institute of Technology
Cambridge, Massachusetts 02139 and vertebrates (Hynes and Zhao, 2000). Indeed, that is
the entire set of integrins in Caenorhabditis elegans; one
 subunit and two  subunits forming two integrins.
Orthologs of these two integrins are recognized in Dro-In their roles as major adhesion receptors, integrins
sophila melanogaster and in vertebrates, although ver-signal across the plasma membrane in both directions.
tebrates have expanded each set (Figure 1). One setRecent structural and cell biological data suggest
(blue in Figure 1) recognizes the tripeptide sequence,models for how integrins transmit signals between
RGD, in molecules such as fibronectin and vitronectintheir extracellular ligand binding adhesion sites and
in vertebrates and tiggrin in Drosophila, whereas thetheir cytoplasmic domains, which link to the cytoskel-
other set (purple in Figure 1) mediates adhesion to base-eton and to signal transduction pathways. Long-range
ment membrane laminins. It is plausible that evolutionconformational changes couple these functions via
of integrins was necessary to allow the cell-matrix adhe-allosteric equilibria.
sion intrinsic to metazoa, and as diploblastic organisms
evolved, the two cell layers may have evolved separateIntegrins are the major metazoan receptors for cell adhe-
integrins to mediate their asymmetric interactions withsion to extracellular matrix proteins and, in vertebrates,
the basal lamina; representatives of these two primordialalso play important roles in certain cell-cell adhesions.
integrins are detected in all higher metazoan phyla.In addition to mediating cell adhesion, integrins make
transmembrane connections to the cytoskeleton and Expansions of the integrin subunit set have occurred
activate many intracellular signaling pathways. Since in different phyla. Figure 1 shows the complete mamma-
the recognition of the integrin receptor family around lian set (based on extensive searches of the human and
15 years ago (Hynes, 1987), they have become the best- mouse genomic sequences, C.A. Whittaker and R.O.H.,
understood cell adhesion receptors. Integrins and their unpublished data), comprising 8  and 18  subunits,
ligands play key roles in development, immune re- so far known to assemble into 24 distinct integrins. Or-
sponses, leukocyte traffic, hemostasis, and cancer and thologs of more than half these subunits have, so far,
are at the heart of many human diseases—genetic, auto- been found only in chordates, including most of the 
immune, and others. They are the target of effective subunits and all the nine  subunits that have an extra
therapeutic drugs against thrombosis and inflammation, inserted domain, known as an I or A domain (see later).
and integrins are receptors for many viruses and bac- In addition to the ancient RGD and laminin receptor
teria. subfamilies mentioned above, vertebrates have a set of
Because of these multifarious functions, integrins collagen receptors with inserted I/A domains (1, 2,
have been and are being studied intensively and there 10, 11) and a pair of related integrins (41, 91),
has been continuous, rapid progress over the past 15 which recognize both ECM proteins such as fibronectin
or so years (averaging over a 1000 papers a year for and Ig-superfamily cell surface counterreceptors such
the past decade). Over the past year there have been as VCAM-1. Vertebrates also have a set of leukocyte-
particularly rapid advances in understanding integrin specific integrins (Figure 1), which also recognize Ig-
structure and function because of the elucidation of the superfamily counterreceptors and mediate heterotypic
3D structures of one integrin (Xiong et al., 2001, 2002) cell-cell adhesion. Most integrins recognize relatively
and parts of others. These structural analyses have re- short peptide motifs and, in general, a key constituent
vealed some surprises but are also beginning to make residue is an acidic amino acid (see more below). The
sense of an enormous body of prior data on integrins. ligand specificities rely on both subunits of a given 
In this review, I will first give a brief overview of the heterodimer and are significantly more complex than
integrin family to set the context and then review the shown in Figure 1 (see reviews cited in Figure 1 for
recent structural data and experiments arising from more details about the diverse ligand specificities of
them, which give insight into some long-standing ques- integrins).
tions concerning integrin functions. It is impossible to Each of the 24 integrins shown in Figure 1 appears
be exhaustive in such a review of integrins, so I have to have a specific, nonredundant function. In part, this
resorted to summary figures and tables and cited other is evident from the details of their ligand specificities
reviews for more details on specific aspects. (not shown in Figure 1) but is most clearly shown by the
phenotypes of knockout mice (Table 1). Genes for the
The Integrin Receptor Family: Evolution  subunits and all but four of the  subunits have been
and Complexity knocked out and each phenotype is distinct, reflecting
Integrins are restricted to the metazoa; no homologs the different roles of the various integrins. The pheno-
are detected in prokaryotes, plants, or fungi (Whittaker types range from a complete block in preimplantation
development (1), through major developmental defects
(4, 5, v, 8), to perinatal lethality (3, 6, 8, v, 4,1Correspondence: rohynes@mit.edu
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in controlling integrin functions but there is not space
here to review the integrin-cytoskeleton links; details
can be found in recent reviews (Zamir and Geiger, 2001;
van der Flier and Sonnenberg, 2001).
In part related (both in cause and in effect) to the
integrin-mediated assembly of cytoskeletal linkages, li-
gation of integrins also triggers a large variety of signal
transduction events (Figure 2) that serve to modulate
many aspects of cell behavior including proliferation,
survival/apoptosis, shape, polarity, motility, gene ex-
pression, and differentiation. These signal transduction
pathways are complex, like those emanating from re-
ceptors for soluble factors (e.g., G protein-coupled and
kinase receptors). Indeed, many integrin-stimulated
pathways are very similar to those triggered by growth
factor receptors and are intimately coupled with them
(Figure 2). In fact, many cellular responses to soluble
growth factors, such as EGF, PDGF, LPA, and thrombin,
Figure 1. The Integrin Receptor Family etc., are dependent on the cell’s being adherent to a
substrate via integrins. That is the essence of anchorageIntegrins are  heterodimers; each subunit crosses the membrane
once, with most of each polypeptide (1600 amino acids in total) dependence of cell survival and proliferation and integ-
in the extracellular space and two short cytoplasmic domains (20–50 rins lie at the basis of these phenomena (Assoian, 1997;
amino acids). The figure depicts the mammalian subunits and their Schwartz and Assoian, 2001; Frisch and Screaton,
 associations; 8  subunits can assort with 18  subunits to form
2001). It is now very well established that integrin-medi-24 distinct integrins. These can be considered in several subfamilies
ated signals are necessary in normal cells to block apo-based on evolutionary relationships (coloring of  subunits), ligand
ptosis (via PI3-kinase and Akt) and to stimulate cell cyclespecificity and, in the case of 2 and 7 integrins, restricted expres-
sion on white blood cells.  subunits with gray hatching or stippling progression (via ERK and cyclin D1, etc.). In oncogeni-
have inserted I/A domains (see text). Such  subunits are restricted cally transformed cells, these anchorage (integrin)-
to chordates, as are 4 and 9 (green) and subunits 2-8. In con- dependent signals are instead provided by oncogenes
trast,  subunits with specificity for laminins (purple) or RGD (blue)
or by loss of tumor suppressor genes. Again, this is tooare found throughout the metazoa and are clearly ancient (see text).
complex an area to review here in detail and the readerAsterisks denote alternatively spliced cytoplasmic domains. A few
is referred to more specialized reviews; see Figure 2,extracellular domains are also alternatively spliced (not shown). Fur-
ther information on integrin subunit structures and details of ligand which summarizes the main messages—integrins are
specificity are given in several extensive reviews (Hemler, 1999; full-fledged signal transduction receptors, at least as
Plow et al., 2000; van der Flier and Sonnenberg, 2001). important to cells as more traditional growth factor re-
ceptors.
8) and defects in leukocyte function (L, M, E, 2,
Regulation of Integrin Function: Activation
7), inflammation (6), hemostasis (IIb, 3, 2), bone
and Inactivationremodeling (3), and angiogenesis (1, 3) as well as
Many integrins are not constitutively active; they canothers (see Table 1; Hynes, 1996, 2002; DeArcangelis
be, and often are, expressed on cell surfaces in an inac-and Georges-Labouesse, 2000; Sheppard, 2000; Bou-
tive or “OFF” state, in which they do not bind ligands andvard et al., 2001). There is not space here to discuss
do not signal. This is very important for their biologicalthe details of all these phenotypes; the relevant point is
functions, as is most evident from considering integrinsthat the integrins play diverse and important roles in
on circulating blood cells.most biological processes. How do they accomplish
The major platelet integrin, IIb3, also known asthis?
GPIIb/IIIa, is present at high density on circulating plate-
lets where it is inactive. If it were not, platelets would
bind their major ligand, fibrinogen, from the plasma andTransmembrane Connections and Signaling
In addition to their roles in adhesion to ECM ligands or aggregate, leading to thrombosis. On platelet activation,
IIb3 is activated from within the cell, so that it cancounterreceptors on adjacent cells, integrins serve as
transmembrane mechanical links from those extracellu- bind fibrinogen, von Willebrand factor, and fibronectin,
leading to strong adherence to the vessel wall and, bylar contacts to the cytoskeleton inside cells. For all integ-
rins except64, the linkage is to the actin-based micro- crosslinking via fibrinogen, to aggregation with other
platelets. The importance of this activation of IIb3 forfilament system, which integrins also regulate and
modulate. The 4 subunit differs from all the others; its hemostasis is clear from the phenotypes of mice lacking
either subunit (see Table 1); these mice show majorcytoplasmic domain being much larger, 1000 amino
acids long instead of around 50, and making connec- defects in hemostasis and have a bleeding disorder that
is an excellent model of the human genetic diseasetions to intermediate filaments instead of to actin. The
submembrane linker proteins connecting the cyto- Glanzmann thrombasthenia (GT), which arises from mu-
tations in the genes for IIb or 3 (Kato, 1997). Antago-plasmic domains of integrins to the cytoskeleton are
multiple and their interactions are complex. We will re- nists of IIb3/fibrinogen binding, either antibodies or
low molecular reagents based on the integrin recogni-turn later to a discussion of the roles of some of them
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Table 1. Integrin Gene Knockout Phenotypes
1 V, F No immediately obvious developmental defects, reduced tumor Gardner et al., 1996; Pozzi
vascularization et al., 2000, 2002
2 V, F Few immediately obvious developmental defects, delayed platelet Holtkotter et al., 2002; Chen
aggregation and reduced binding to monomeric collagen, et al., 2002
reduced mammary gland branching
3 P Kidney tubule defects, reduced branching morphogenesis in lungs, Kriedberg et al., 1996;
mild skin blistering, lamination defects in neocortex DiPersio et al., 1997;
Anton et al., 1999
4 E11/14 Defects in placenta (chorioallantoic fusion defect) and heart Yang et al., 1995; Arroyo et
(epicardium, coronary vessels). Chimeras show defects in al., 1996, 1999
hematopoiesis.
5 E10-11 Defects in mesoderm (posterior somites) and vascular development, Yang et al., 1993; Goh et al.,
neural crest apoptosis. Chimeras show muscular dystrophy 1997; Taverna et al.,
1998
6a P Severe skin blistering, other epithelial tissues also defective. Georges-Labouesse et al.,
Lamination defects in cortex and retina. 1996, 1998
7 V, F Muscular dystrophy, defective myotendinous junctions Mayer et al., 1997
8 P Small or absent kidneys, inner ear hair cell defects Muller et al., 1997;
Littlewood Evans et al.,
2000
9 V Die within 10 days of birth, chylothorax due to lymphatic duct defect Huang et al., 2000
10 Not reported
11 Not reported
v E10/P Two classes: embryonic lethality due to placental defects, perinatal Bader et al., 1998; McCarty
lethality with cerebral vascular defects probably due to et al., 2002
neuroepithelial defects, cleft palate. Most blood vessels develop
normally
IIbb V, F Hemorrhage, no platelet aggregation Tronik-Le Roux et al., 2000
L V, F Impaired leukocyte recruitment Schmits et al., 1996
M V, F Defective phagocytosis and apoptosis of neutrophils, mast cell Coxon et al., 1996; Tang et
development defects, adipose accumulation. al., 1997; Dong et al.,
1997
X Not reported
D Not reported
E V, F Greatly reduced numbers of intraepithelial lymphocytes. Schon et al., 1999
1 E6.5 Peri-implantation lethality, ICM deteriorates, embryos fail to Fa¨ssler and Meyer, 1995;
gastrulate. Extensive analyses of chimeras. Stephens et al., 1995;
Brakebusch et al., 1997
2c V, F Leukocytosis, impaired inflammatory responses, skin infections, T Scharffetter-Kochanek et
cell proliferation defects al., 1998
3b V, F Hemorrhage, no platelet aggregation, osteosclerosis, Hodivala-Dilke et al., 1999;
hypervascularisation of tumors McHugh et al., 2000;
Reynolds et al., 2002
4a P Severe skin blistering, other epithelial tissues also defective van der Neut et al., 1996;
Dowling et al., 1996
5 V, F No immediately obvious developmental defects Huang et al., 2000
6 V, F Inflammation in skin and airways, impaired lung fibrosis—all Huang et al., 1996; Munger
probably due to failure to activate TGF et al., 1999
7 V Deficits in gut-associated lymphocytes—no Peyer’s patches, Wagner et al., 1996
reduced intraepithelial lymphocytes (IEL).
8 E10/P Two classes: embryonic lethality due to placental defects, perinatal Zhu et al., 2002
lethality with cerebral vascular defects probably due to
neuroepithelial defects. Most blood vessels develop normally.
Reference citations are listed but not given in the reference list. They can be found in PubMed or in several extensive reviews, which also
discuss the implications of the results as well as work with chimeric mice and recent work using conditional and tissue-specific ablation of
integrins (Hynes, 1996; De Arcangelis and Georges-Labouesse, 2000; Sheppard, 2000; Bouvard et al., 2001).
Abbreviations: E, embryonic lethal (day of lethality); P, perinatal lethal; V, viable; F, fertile.
a,b,c Human mutations in these genes lead to disease (Hogg and Bates, 2000)
a64 Epidermolysis bullosa (JEB-PA)—skin blistering (Pulkkinen and Uitto, 1999)
bIIb3 Glanzmann thrombasthenia (GT)—bleeding (Kato, 1997)
c2 Leukocyte adhesion deficiency (LAD)—failure in leukocyte recruitment (Etzioni et al., 1999)
tion sequence, are effective antithrombotic drugs (Col- tors GPVI and the integrin 21. This last is an example
of another important general principle, namely that in-ler, 1997; Scarborough and Gretler, 2000). The activation
of IIb3 is triggered by thrombin, ADP, or epinephrine, tegrins frequently intercommunicate, serving to activate
(as in this case) or inhibit each other (Schwartz andall of which act through G protein-coupled receptors, or
by von Willebrand factor signaling through its receptor Ginsberg, 2002; Hynes, 2002).
Leukocytes offer other examples of the importance(GPIb/V/IX), or by collagen signaling through its recep-
Cell
676
Figure 2. Integrin Signaling
A decade ago, ideas about integrin signaling
were in their infancy (Hynes, 1992). It was
clear that integrins synergized with other cell
surface receptors including growth factor re-
ceptors to activate largely unknown signaling
pathways to affect cell proliferation and dif-
ferentiation, cell shape and migration, and
other events. These signal transduction
mechanisms could be subverted by onco-
genes such as pp60sre to give anchorage inde-
pendence of growth. Our current view re-
mains the same in outline but many detailed
signal transduction pathways have now been
elucidated.
The major signal transduction pathways and
many of the key players in them are shown,
leading to the major effects on cell behavior
mediated by integrins, often acting in concert
with G protein-coupled or kinase receptors
for soluble factors. The major submembra-
nous, integrin-associated links between integrins and these signal transduction pathways are contained within the pink-purple pentagon
beneath the clustered integrins. Details of the interactions of these linker/adaptor proteins and of the signal transduction pathways are omitted,
as are other known players in these processes. Readers are referred to several excellent reviews for further details (Clark and Brugge, 1995;
Schwartz et al., 1995; Yamada and Miyamoto, 1995; Clark and Hynes, 1997; Giancotti and Ruoslahti, 1999; Danen and Yamada, 2001; Wu
and Dedhar, 2001; Schwartz and Ginsberg, 2002; Miranti and Brugge, 2002).
of inactive integrins and their regulated activation. Mem- lation of integrin function from within the cell has com-
monly been called “inside-out” signaling to distinguishbers of the 2 integrin subfamily (also known as CD11/
18) are expressed on most white blood cells but, when it from “outside-in” signaling, as depicted in Figure 2
(Hynes, 1992; Ginsberg et al., 1992). Both obviously in-these cells are “resting,” these integrins become inac-
tive. When the cells become activated, for example by volve transmembrane signals, the nature of which has
been difficult to decipher. Major insights come fromcytokines, the 2 integrins are rapidly activated and the
cells become adhesive for their counterreceptors, in this recent structural information on integrins and from ex-
periments stimulated by and/or reinterpreted in lightcase, Ig superfamily molecules such as ICAMs. These
are expressed on endothelial cells, allowing attachment of the structural results, and we will return later to a
discussion of the nature of integrin activation.of leukocytes to the vessel wall, or on other cells,
allowing phenomena such as phagocytosis, cytotoxic
killing, or lymphocyte help. As in the case of platelets, Integrin Structure: Extracellular Domains
The first domain of integrins to be crystallized was the I/Ait is important that the 2 integrins are inactive on the
surfaces of resting leukocytes (to avoid inflammation) domain inserted into half of the mammalian  subunits
(Figure 1). Lee et al. (1995a) determined the structure ofand that they can be rapidly activated (to allow immune
function). Defects in either have pathological conse- this domain fromM2 (CD11b/CD18, CR3) and showed
it to be a Rossmann fold with a core of parallel  sheetsquences. Clear support for the importance of these pro-
cesses comes from the phenotypes of mice lacking one surrounded by amphipathic  helices. Within the ex-
tended family of Rossmann folds, the integrin I/A do-or more of the 2 integrins or their ligands (Table 1;
Rosenkranz and Mayadas, 1999) and from the genetic mains form a subset of the larger group of VWA domains
found in a wide variety of proteins (Tuckwell, 1999; Whit-disease leukocyte adhesion deficiency (LAD), which
arises from mutations in the gene for 2 integrin. LAD taker and Hynes, 2002). VWA domains are around 180
amino acids long and many appear to be involved inpatients suffer from leukocytosis and the failure to re-
cruit leukocytes to sites of infection, leading to early protein-protein interactions. The I/A domains of integrin
 subunits comprise the ligand binding sites of thesedeath (Etzioni et al., 1999). In contrast, blockade of 2
integrins, and of 4 integrins, which mediate similar integrins.
Lee et al. (1995a) defined a metal ion coordination sitefunctions on lymphocytes, is a very promising avenue
for therapy of a variety of inflammatory and autoimmune at the “top” of the I/A domain of M, involving residues
from three separate loops of the I/A domain. Interest-diseases (Gottlieb et al., 2000; Jackson, 2002).
While these vascular processes offer particularly clear ingly, a glutamate from an adjacent molecule in the crys-
tal formed part of the coordination sphere. It was alreadyexamples of the importance of inactivation and activa-
tion of integrin function, not all integrins have been well established that integrins require divalent cations
for ligand binding and that an aspartate (D) or glutamateshown to undergo such extremes of activity. However, it
is believed that many, perhaps all, integrins may behave (E) residue is key to the integrin recognition site of all
ligands (including ICAM-1, a ligand for M2). This hadsimilarly, albeit in a less absolute and more localized
fashion, during processes such as cell migration, neurite led to the idea that the ligand D/E might participate
together with residues from the integrin in joint coordina-outgrowth, and so forth, when it is important for cells to
regulate their adhesion in a temporal and spatial fashion tion of a divalent cation. The structure determined by
Lee et al. (1995a) fitted this idea very well and they(Lauffenburger and Horwitz, 1996). This concept of regu-
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Figure 3. Integrin I/A Domain Structure and
Conformational Change
(A) Comparison of I/A domain structures of
2 (left) and M (right). In each case, regions
showing large changes between the two
states; open/liganded (blue) and closed/unli-
ganded (yellow) are indicated, and the shifts
on ligation are shown by red arrows. Note the
shift from the C helix (red; specific to collagen
binding I/A domains) into the 6 helix and
the large downward shift of the C-terminal 7
helix on binding of ligand to 2. M shows a
very similar downward shift of the C-terminal
helix.
(B) Close-up of the movements of the metal
ion and loops around the MIDAS site in 2
(left) and M (right) with color-coding as in
(A). Again note the strong similarity in the con-
formational changes occurring in the two do-
mains. The movement of the loops is coordi-
nated with the movement of the metal ion,
which switches its coordination from a D in
loop L3 to a T in loop L1. Changes in L1 and
L2 lead to the reorganization of C and 7
shown in (A).
(C) Stereo diagram of the MIDAS motif of 2
with the glutamate residue (E) from the ligand
(yellow) coordinating the metal ion (blue).
Residues from the loops of the I/A domain
coordinate the metal ion either directly or
through water molecules (). An additional
residue (E256 from L3) has been omitted for
clarity.
All panels from Emsley et al. (2000).
coined the term metal ion-dependent adhesion site mational change within the I/A domain and this was
elegantly confirmed by the determination of the struc-(MIDAS). They also pointed out a homologous segment
embedded within the  subunit and sharing hydropathy ture of the I/A domain of 2 with and without a model
ligand based on the recognition sequence in collagenand secondary structure predictions and a MIDAS motif.
This segment of the 3 subunit had already been impli- (Figure 3; Emsley et al., 1997, 2000). Comparisons
among all the I/A domain structures lead to the clearcated in ligand binding by crosslinking, genetic, and
mutagenesis data (D’Souza et al., 1988; Bajt and Loftus, deduction that the ligand does indeed coordinate the
metal ion in the MIDAS site via a carboxylate group and1994; Loftus et al., 1994). This prediction was followed
up by more elaborate secondary structure predictions this is coupled to alterations in metal coordination by
residues within the integrin MIDAS motif. These in turn(Tozer et al., 1996; Tuckwell and Humphries, 1997;
Huang et al., 2000), and refined HMM models now reli- are coupled to conformational shifts within the domain:
lateral movements of the loops containing the MIDASably predict a VWA domain within integrin  subunits.
These conclusions have been confirmed within the last residues and longer-range movements in the C-terminal
helix of the I/A domain, which moves around 10 A˚ downyear by the determination of the structure of the entire
extracellular domain of integrin v3 (see below). the side of the domain when ligand binds (Figure 3).
Liddington and colleagues (Lee et al., 1995b; Loftus andAdditional structures of I/A domains followed and it
became clear that the domains could take on two con- Liddington, 1997) noted the strong parallels between
these conformational changes in I/A domains and thoseformations, “open” and “closed,” differing in the coordi-
nation of the metal at the MIDAS site (Lee et al., 1995b; occurring in GTPases such as ras and G proteins, which
also contain Rossmann nucleotide binding folds. It isQu and Leahy, 1995, 1996; Emsley et al., 1997). It was
proposed that ligand binding was coupled to a confor- easy to imagine how such conformational changes
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could propagate to the rest of the molecule, to which refer to as I-EGF repeats. The four I-EGF repeats are
followed by a C-terminal disulfide-bonded  sheet do-the I/A domain is coupled via its adjacent N and C ter-
mini, and we will return later to this important allosteric main termed the -tail domain.
As mentioned, this structure confirmed many predic-property of integrins.
Xiong et al. (2000) expressed I/A domains of M that tions and conformed with much preexisting data con-
cerning integrin structure (see Humphries, 2000, 2002;adopt each of the two forms (open or closed) and
showed that only the open form binds ligands. Springer Shimaoka et al., 2002, for relevant reviews relating earlier
data to the structure). The big surprise was that, insteadand colleagues have also exploited the structural infor-
mation to produce I/A domains of L locked in the open of being extended as depicted in Figure 4B and as ex-
pected from published EM images of integrins, the v3and closed states by disulfide bonds engineered into
the C-terminal helix to lock it into the up (closed) or integrin in the crystal structure was bent over at a 135
angle with a “genu” between the thigh and calf domainsdown (open) position and shown that these two forms
differ markedly in affinity for ligand (Lu et al., 2001a; of v and a similar bend in the I-EGF 2/3 region of the
3 leg (Figure 4A). This surprising structure raises veryShimaoka et al., 2001, 2002). The open form is high
affinity or “active” and the closed form is low affinity or interesting questions and has already stimulated experi-
ments to which I will return below.“inactive,” and the conformational switch between them
is coupled with ligand binding or with known activation The structure determined by Xiong et al. (2001) was
obtained in a Ca2 buffer and lacked bound ligand, con-stimuli such as activating antibodies or Mn2 ions.
Half the mammalian  subunits and all known non- ditions usually yielding inactive integrins. The MIDAS
motif did not have a clear cation engaged, although anchordate integrins lack an inserted I/A domain (Figure
1), but it is clear that these  subunits also contribute adjacent site (ADMIDAS) did and other cations bind at
other sites within both subunits. Subsequent structuresligand binding specificity. How do they do that? Springer
(1997) predicted that the 7-fold repeat in the extracellular obtained after diffusing cycloRGDF and Mn2 into the
crystal showed cycloRGDF bound at the  interfacedomain of all  subunits folds into a 7-bladed  propeller
like that in the  subunit of G proteins (Wall et al., 1995; with the arginine residue binding the propeller domain of
the  subunit and the aspartate joining the coordinationLambright et al., 1996; Sondek et al., 1996) and predicted
that this might complex with the I/A domain embedded sphere of a Mn2 ion bound at the MIDAS site (Figure
4C; Xiong et al., 2002). Changes occurred in the loopswithin the integrin  subunit by analogy with the G/G
complex in G proteins. This prediction has also been at the top of the I/A domains, similar to those seen in
-I/A domains, but the 10 A˚ shift in the C-terminal helixconfirmed by the v3 structure.
The solution by Arnaout and colleagues of the crystal characteristic of ligand bound I/A domains from  sub-
units was not observed in the 3 I/A domain. Severalstructure of the extracellular domain of v3 (Xiong et
al., 2001) represents a truly major advance in the integrin possibilities have been suggested: (1) the 3 I/A domain
is constitutively active, even in the absence of ligandfield. In addition to confirming the predictions of an I/A
domain within the  subunit and of a -propeller domain (Xiong et al., 2001, 2002), (2) the lattice contacts in the
crystal prevent the full conformational change and acti-within the  subunit in an association very like that of
G and G, it revealed the structure of much of the vation (Liddington, 2002), or (3) activation of the I/A do-
main in  subunits occurs somewhat differently (Mouldrest of the extracellular domains of both subunits (Figure
4; Xiong et al., 2001, 2002). The propeller domain and the et al., 2002; Liddington, 2002). Mould et al. (2002) report
an activation-dependent antibody that binds the1 helix-I/A domain are complexed to form the ligand binding
head of the integrin, which is attached to two legs, one at the base of the -I/A domain near the contact with the
hybrid domain. Many function-blocking and -activatingfrom each subunit, as predicted from a large body of
electron microscopic, biophysical, and other data. The antibodies bind the 1 and 2 helices in this part of the
-I/A domain (Takada and Puzon, 1993), also suggestingN-terminal propeller domain of the  subunit is attached
to an elongated leg formed of three  sandwich domains a propagated conformational change in this region not
seen in the cycloRGDF-v3 crystal.termed thigh, calf1, and calf2. The  subunit domain
organization is a bit more complex; although the -I/A Much of the top surface of the propeller is occluded
by the apposed -I/A domain in the crystal structuredomain is at the distal end of the molecule (furthest from
the C-terminal membrane insertion site), it is not at the (Xiong et al., 2001), including residues known to be in-
volved in interactions with ligands and to contain epi-N terminus of the primary sequence. Instead, it is in-
serted into a loop in a so-called hybrid domain, another topes for blocking antibodies against several integrins
(Humphries, 2000, 2002). It has been known for a long sandwich domain with some homology with I-set Ig
domains. The hybrid-I/A domain unit is preceded in the time that RGD peptides and small ligands can bind integ-
rins that are not fully activated, whereas larger ligandssequence by an N-terminal 54-residue PSI domain,
which in the 3D structure lies below the hybrid-I/A do- such as fibrinogen and fibronectin cannot (Coller, 1986;
Beer et al., 1992). Mould et al. (1997) showed that themain “head” and is disulfide bonded to the distal end
of the  subunit leg. This leg is made up of four tandem RGD of fibronectin interacts with the -I/A domain,
whereas the synergy site in the adjacent Fn3 repeatcystine-rich repeats highly characteristic of integrin 
subunits. The first and second are poorly resolved in interacts with the propeller domain. Dual interaction of
these two sites appears to be necessary for strong bind-the crystal, but the third and fourth are clearly folded
into EGF-like folds. An NMR structure of the second and ing of 51 integrin to fibronectin (Garcia et al., 2002).
These data suggest that a fully active ligand-engagedthird cystine-rich repeats of 2 (Beglova et al., 2002)
confirms their EGF-like pattern including an extra fourth integrin must undergo some opening up at the interface
between the -I/A domain and the propeller domain.cystine pair characteristic of these repeats, which I will
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Figure 4. Three-Dimensional Structure of the
Integrin v3
(A) The structure of the unliganded v3 is
shown as a ribbon diagram with the v sub-
unit in blue and the 3 subunit in red. In the
crystal the integrin is folded over at a bend
or “genu,” with the head (propeller, -I/A, and
hybrid domains) bent over toward the C ter-
mini of the legs which would be inserted into
the membrane in an intact integrin. The do-
mains are hard to see in this view and are
more readily visualized in (B).
(B) The structure in (A) has been unfolded by
straightening it out at the “genu” of the v
subunit by 135 and rotating the thigh 120
around its axis, with similar adjustments to
the 3 structure. The structures of the linker
segments (1 in the v, 2 and 3 in the 3) and
of the PSI domain and I-EGF repeats 1 and
2 are not well resolved and are approximate
estimates only. The structure reveals two legs
(160 A˚  20 A˚) extending from the mem-
brane insertion site at the C termini to the
head at the top. The head is 90 A˚  60 A˚ 
45 A˚ and comprises three domains: a  pro-
peller domain at the N terminus of the v
subunit and an I/A domain inserted into a loop
on the top of the hybrid domain in the  sub-
unit. The N-terminal PSI domain is curled in
below the hybrid domain and is known to be
linked by a disulfide bond to the I-EGF-1 re-
peat, although this connection is not resolved
in the crystal structure. The apposition of the propeller and I/A domains is highly similar to that of G proteins. A 310 helix from the I/A domain
reaches out to the propeller and inserts an arginine residue into the central channel of the propeller. This arrangement is very similar to the
arrangement of a lysine in the 2 helix of the switch II region of G inserted into the propeller domain of G. The asterisk marks the loop into
which I/A domains are inserted in some integrin  subunits, although not v.
(C) Surface representation of the cyclo RGDF peptide bound to the interface between the  subunit propeller (blue) and the  subunit I/A
domain (red). The aspartate (D) of the ligand coordinates a Mn2 ion (cyan) and the arginine (R) binds to aspartate residues in loops on top
of the propeller. The second Mn2 ion (violet) is in the ADMIDAS site.
(A) and (B) are from Xiong et al. (2001); (C) is from Xiong et al. (2002).
This would resemble the separation of the homologous activation of the extracellular domains after we have
reviewed recent data on the cytoplasmic domains ofG and G domains in activated G proteins and seems
a very reasonable working hypothesis for integrins (Lid- integrins to which events at the ligand binding sites must
be coupled.dington, 2002; Liddington and Ginsberg, 2002). Such a
model receives some support from EM images of integ-
rins in the presence of ligand peptides. Hantgan et al. Cytoplasmic Domains: Structures
and Interactions(1999) report some separation of the  and  heads of
IIb3 in the presence of RGD peptides and Takagi et Despite the fact that integrins’ cytoplasmic domains are
much smaller than their extracellular domains (generallyal. (2002) detect changes in the relationship between
the head and the hybrid domain of v3 as a conse- less than 50 amino acids) they play a vital role in integrin
functions and have been the subject of intensive analy-quence of RGD binding. Since the C-terminal helix of
the -I/A domain connects to the hybrid domain, if it sis. Paradoxically we have a less clear picture of their 3D
structure than we do for the large extracellular domains,were to undergo a downward shift like that shown by
the corresponding helix in -I/A domains, that would although recent work has produced some major in-
sights.necessarily be coupled to changes in -I/A-hybrid do-
main organization that could well include rotation away The cytoplasmic domains are the sites of interaction
with, and linkage to, the cytoskeletal and signaling part-from contact with the propeller domain, opening it up
for further interactions with ligands (Figure 5). ners of integrins (see Figure 2). There is an extensive
literature on the many proteins that have been reportedThe v3 integrin lacks an -I/A domain, but the site
of insertion of I/A domains in those  subunits that have to interact with  or  cytoplasmic domains but I will
not attempt to review most of that work (see Burridgeone falls between blades 2 and 3 of the propeller domain,
and this position is marked in Figures 4 and 5. Since and Chrzanowska-Wodnicka, 1996; Critchley et al.,
1999; Calderwood et al., 2000; Zamir and Geiger, 2001,-I/A domains contain the ligand binding sites of the
corresponding integrins, we need to consider how li- for reviews). For our present considerations, it is most
relevant to consider data that indicate that integrin cyto-gand binding may differ between the two classes of
integrin, those with and without -I/A domains. We will plasmic domains can regulate the activation state of
integrins; that is, affect the structure and function of thereturn to consider further models for ligand binding and
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Figure 6. Interactions between and with Integrin Cytoplasmic Do-
mainsFigure 5. Hypothetical Models for Ligand binding to Integrin Heads
(A) Sequences of the cytoplasmic tails of IIb and 3. The mem-(A) An integrin without an I/A domain in the  subunit, such as v3
brane-spanning segment is usually considered to end at the W(note; only the head region is shown). A small ligand such as cyclo
within the darker gray shaded area (lipid bilayer). The immediatelyRGDF binds at the interface between the propeller and the -I/A
membrane-proximal segments are highly conserved (red denotesdomain (see Figure 4). The model proposes that the C-terminal helix
conservation in the vast majority of subunits, lilac denotes conserva-(orange) moves down, causing the -I/A domain (pink) to rotate
tion in more than half). Conserved NxxY motifs are highlighted inaway from the propeller domain opening up the top of the propeller
yellow. Deletion of the conserved membrane-proximal segmentto engage larger ligands such as fibronectin (lilac). It is known that
from either subunit leads to activation, as do point mutations markedthe RGD motif in fibronectin engages the -I/A domain while the
by asterisks (see text). The proposed salt bridge between R995 andsynergy site in the adjacent Fn3 domain engages the propeller
D723 is marked by a red bar (Hughes et al., 1996). The pink bars(Mould et al., 1997), consistent with this model, although the degree
denote regions showing interaction between subunits and the greenof opening shown is hypothetical and could easily vary among in-
bars denote -helical segments, both deduced from NMR data (Vi-tegrins.
nogradova et al., 2002). The purple bar denotes segment of 3(B) An integrin with an -I/A domain such as 21. The ligand,
showing interaction with talin head by NMR (Vinogradova et al.,collagen, binds to the top of the -I/A domain (pale blue) causing
2002) consistent with cell biological results (Calderwood et al., 1999,a 10 A˚ downward shift of the C-terminal helix (Figure 3), which is
2002; Patil et al., 1999). Talin binding also requires Y747 (hatchattached to an extended loop containing a conserved glutamate
mark). Since the affinity of talin head for 3 tail is much higher than(red dot). It is proposed that this could bind to the MIDAS site in
that between the two tails, binding of talin undoes the clasp betweenthe -I/A domain (Alonso et al., 2002) and act upon it as a ligand
the cytoplasmic domains in the same way as mutations in the mem-relay. The -I/A domain is proposed to transmit conformational
brane-proximal region (asterisks). Armulik et al. (1999) report thatchange to the hybrid domain as in (A). Springer and colleagues
the conserved membrane-proximal segments can be buried in the(Shimaoka et al., 2002) have concentrated on inside-out activation
lipid bilayer (lighter gray shading). If so, then the transmembraneof 2 integrins and thus have focused on how the -I/A domains
segments are atypically long (28–30 residues) and Armulik et al.become activated. They have suggested that the C-terminal helix
suggest that interactions with cytoplasmic proteins could pull theacts like a bell rope to pull open the I/A domain. This is the reciprocal
conserved segments out of the bilayer, offering an alternative orof the ligand-relay model. The change is an allosteric one and the
additional way in which binding of proteins such as talin could alterequilibrium can be driven from either end.
integrin conformation leading to activation (see also Figure 7B).
(B) Talin can be activated for binding to  tails by cleavage (Yan et
al., 2001) to release the FERM domain-containing head (blue) or by
extracellular domains. There is a considerable body of interaction with PIP2 (Martel et al., 2001). In each case, the talin
data indicating that the cytoplasmic domains of the  head binds the  cytoplasmic domain leading to separation of the
tails (see [A] and text). Intact talin does not interact with integrinand  subunits can interact to control the activation
tails and is depicted as folded upon itself with the head domainstates of integrins. These analyses have proceeded fur-
occluded by the tail of talin, by analogy with ERM proteins (Pearsonthest for the platelet integrin, IIb3, which as discussed
et al., 2000), although the tertiary structure of talin is unknown. Theearlier is tightly regulated so that it is inactive on resting talin tail comprises a series of short -helical segments (yellow) and
platelets but rapidly activated by thrombogenic stimuli. an actin binding domain (red).
Ginsberg and colleagues have investigated the roles of
the IIb and 3 cytoplasmic domains in this regulation.
They have shown that the short IIb cytoplasmic domain tion of either one to alanine yields a constitutively active
integrin, whereas a charge reversal, IIbR995D/3D723R,acts as a negative regulator of activation. Deletion of
the entire domain (see Figure 6A) or of just the highly restored the inactive state (Hughes et al., 1996). Based
on these and other results, Ginsberg and colleaguesconserved GFFKR sequence produces a constitutively
active integrin (O’Toole et al., 1991, 1994). Similarly, the suggested several models, all relying on interaction be-
tween the membrane-proximal segments of IIb and 3conserved membrane-proximal segment of 3 is also
necessary (Hughes et al., 1995). They proposed that to restrain the integrin in an inactive state (Williams et
al., 1994; Woodside et al., 2001). Separation, twisting,R995 of IIb forms a salt bridge with D723 of 3; muta-
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pistoning, and hinging of the tails were all considered integrin tails, most often those of  subunits. Others of
as mechanisms to allow activation. More recent data these could act similarly to talin head or, alternatively,
favor models involving separation of the cytoplasmic could bind elsewhere in the tail, such as the distal por-
domains as a key step in integrin activation. Evidence tion of  tail, which does not appear to interact with the
comes from recent NMR analyses and from cell biologi-  tail (Figure 6A).
cal studies.
Binding between the cytoplasmic domains of IIb and Integrin Activation: Transmembrane Connections
3 could be detected by surface plasmon resonance and Long-Range Conformational Changes
and was ablated by deletion of KVGFFKR or by an R995A If activation of integrins by inside-out signaling involves
mutation (Vallar et al., 1999). The affinity was low (Kd 	 separation of the  and  cytoplasmic tails, how is that
7–50 
M depending on divalent cation concentration), signal transmitted to the ligand binding site(s) 10–20 nm
which may explain why initial efforts to determine struc- away at the far end of the extracellular domain? Recent
tures of the interacting domains were largely unsuccess- results are beginning to reveal possible mechanisms,
ful (Ulmer et al., 2001; Li et al., 2001). However, Weljie despite the fact that there is not a structure for an intact
et al. (2002) detected-helical structure and intersubunit integrin, only for the separate intracellular and extracel-
interactions using synthetic peptides representing the lular domains.
membrane-proximal segments. Vinogradova et al. 2 integrins, like IIb3, are dependent on their mem-
(2002) demonstrated interactions between membrane- brane-proximal cytoplasmic domains to maintain an in-
proximal helices in both subunits, using the entire cyto- active state; deletion of either  or  segments yields
plasmic domains, and also demonstrated that they were active integrins (Lu et al., 2001b). Furthermore, replace-
disrupted by point mutations (F992A or R995D) already ment of the L and 2 tails by, respectively, acidic and
known to interfere with inactivation by IIb cytoplasmic basic coiled-coil domains restored the inactive state.
domain in the intact integrin (see earlier discussion). This is analogous to the charge-reversal experiment with
These data are summarized in Figure 6A, which also IIb3 and confirms that  tail associations also re-
collects together information from a different, comple- strain 2 integrins in an inactive state. To take the analy-
mentary set of experiments. sis further, Takagi et al. (2001) eliminated both the tails
Calderwood et al. (1999, 2002) showed that the head and the transmembrane domains from 51 and re-
domain of talin binds to the cytoplasmic domains of placed them with acidic and basic coiled coils joined
3 and other  subunits via a PTB domain within the by a disulfide bond. This generated a soluble 51 di-
conserved FERM domain of talin; Y747 of 3 is neces- mer. As predicted, this clamped, soluble 51 did not
sary for this interaction. The NPLY motif is believed to bind its ligand, fibronectin, but it could be activated by
form a  turn, and NMR data on 3 cytoplasmic domain cleaving the C-terminal clamp; that is, by allowing the
support this idea (Ulmer et al., 2001). Vinogradova et al.
 and  stalks (legs) to separate, which was confirmed
(2002) therefore analyzed the effects of talin head on by EM. This experiment shows that the C-terminal cyto-
the NMR signals of theIIb and3 cytoplasmic domains; plasmic domain clasp or the engineered C-terminal
talin head bound to 3 but not to IIb. The interactions
clamp, whether inside or outside the membrane, con-
extended from K716 to N744, completely overlapping
strain integrins in an inactive state but release of these
the region of 3 interaction with IIb (see Figure 6A).
constraints, allowing separation of the stalks/legs of the
Furthermore, talin head ablated the interaction between
extracellular domains, leads to activation of the ligandtheIIb and3 tails (Vinogradova et al., 2002), consistent
binding site in the head.with its much higher affinity for 3 tail (Kd 100 nM; The idea that conformational changes in the extracel-Calderwood et al., 1999, 2002). Thus, the head of talin
lular domain near the membrane can be linked tobinds to the 3 tail and separates it from the IIb tail.
changes in the ligand binding domain in the head ofTalin head was also shown to bind to and activate
integrins is far from a new one. A decade ago Weisel etintegrins (Calderwood et al., 1999, 2002), entirely consis-
al. (1992) demonstrated that IIb3 bound to fibrinogentent with the model that interactions between IIb tail
tends to show widely separated tails. This is effectivelyand 3 tail keep the integrin in an inactive state and
the reciprocal result of the experiment of Takagi et al.separation is necessary for activation (see Figure 6B).
(2001) with 51 and fibronectin. In another early experi-In order for talin’s head domain to trigger this activation,
ment, Du et al. (1993) showed cooperative activationit must be exposed. This can be accomplished by ex-
between the binding of fibrinogen to the head of thepressing recombinant fragments of talin (Calderwood
IIb3 integrin and binding of a monoclonal antibody toet al., 1999, 2002; Patil et al., 1999), by calpain cleavage,
the first 90 amino acids of the 3 stalk adjacent to thewhich separates the head from the tail (Yan et al., 2001),
membrane. The distance between these two sites asor by phosphatidyl inositols (Martel et al., 2001) as de-
revealed by EM was 16 nm. The antibody had originallypicted in Figure 6B. The mapping of the interaction to
been isolated as recognizing a ligand-induced bindinga PTB domain within the talin head (Calderwood et al.,
site (anti-LIBS) and its binding was enhanced by fibrino-2002), which binds to the NPxY motif conserved in 3
gen binding to the head of the integrin. Importantly,and in most other integrin  subunits, raises the very
binding of the antibody also enhanced the affinity of theinteresting possibility that other PTB-containing pro-
integrin for fibrinogen, i.e., the activation was reciprocal.teins may also interact with  tails leading to activation
So we now have a picture of long-range conforma-of integrins (Liddington and Ginsberg, 2002). Among
tional changes linking the C-terminal ends of an integ-candidates for such a role is FAK, which like talin has
rin’s legs, i.e., the membrane-proximal regions both out-a FERM domain containing a PTB domain. As mentioned
earlier, multiple proteins have been reported to bind to side and inside the membrane, to ligand binding at the
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head. There is, in fact, a great deal of evidence in support
of this concept, including many activating and activa-
tion-sensitive monoclonal antibodies that frequently
map in the  stalk regions (reviewed in Humphries, 2000,
2002; Shimaoka et al., 2002), as well as biophysical data
(e.g., Hantgan et al., 1999, and earlier work) and the
electron microscopy already mentioned. The challenge
is to understand how conformational changes in the
head domains associated with ligand binding are cou-
pled reciprocally with alterations, probably separation,
at the base of the legs and in the cytoplasm. How can
we fit these results with the newly available structural
data? The structure offers some potential solutions but
also the complication represented by the bent structure
observed in the crystal (Figure 4A).
Xiong et al. (2001, 2002) suggested that the bent form
is the active form of the integrin. However, others have
argued that it is more likely to be the inactive state,
based on details of the conformation of the -I/A domain
and the fact that it was crystallized in the absence
of ligand (Liddington, 2002; Liddington and Ginsberg,
2002; Shimaoka et al., 2002). The latter interpretation
would fit much better with EM images of ligand bound
integrins (Weisel et al., 1992; Du et al., 1993), which
show an extended structure like that shown in Figure
4B. Beglova et al. (2002) mapped epitopes for activation-
specific monoclonal antibodies to specific residues in
Figure 7. Models for Long-Range Allosteric Changes Giving Bidi-
I-EGF repeats 2 and 3 and noted that these residues rectional Signaling by Integrins
would be buried in the bent form of the integrin. They (A) Integrin in its bent form is presumed to be inactive. Activation
proposed, therefore, that the bent form represents the can occur either by ligand binding or by effects on the cytoplasmic
inactive state and that activation occurs by a “switch- domains, leading to straightening and separation of the legs. Alter-
ations in the orientation of the propeller and I/A domains are coupledblade” opening of the integrin into an extended shape
to changes in the hybrid domain (yellow) by movement of the C-ter-and a separation of the legs. Such a conformational
minal helix of the I/A domain (orange). The hybrid domain, in turn,change could expose the epitopes for activation-spe-
is linked to the I-EGF domains (purple) via the PSI domain (green),cific antibodies, many of which are known to bind to
which is disulfide bonded (yellow line) to the first I-EGF domain.
the I-EGF repeats or to the PSI domain, which is also Straightening and separation of the legs exposes activation epi-
buried in the genu (the structure is not well resolved topes in the I-EGF domains (red stars) and in the PSI domain (not
there). Takagi et al. (2002) went on to show that integrins shown). Separation of the cytoplasmic domains is accompanied by
conformational changes in them, allowing binding of cytoplasmicclamped in the inactive state predominantly adopt a
proteins (see Figure 2) and signaling (lightning). All changes arebent shape as seen by EM, whereas integrins activated
reversible equilibria and can operate in either direction, allowingby Mn2 or by cyclo RGDfV were predominantly in an
both outside-in and inside-out signaling. See text for discussion
extended form. They showed that the clamped, bent and references.
form did not bind ligand, whereas the activated, ex- (B) Two models for the proposed straightening up of integrins during
tended form did. Finally they presented evidence that activation. The switch-blade or flick-knife model (Beglova et al.,
2002) and an alternative angle-poise model differ in the way in whichintegrins on cell surfaces can be trapped in a bent and
the C termini of the legs relate to the transmembrane segmentsinactive state by an engineered disulfide bond that,
(which is unknown). The angle-poise model incorporates the possi-when released, allows their activation. These results
bility that the transmembrane helices may be especially long andconform well with the idea that the bent form seen in
could change orientation and/or move in and out of the membrane
the crystal represents the inactive state of the integrin during activation (Armulik et al., 1999; see Figure 6A). The angle-
and that activation comprises straightening and separa- poise model would place the ligand binding site in a more accessible
tion of the legs. This is, of course, also in good agree- position for macromolecular ligands.
ment with the data on cytoplasmic domain separation
(Figure 6, see prior discussion). These concepts are
tion. The latter model would place the head domain in aschematized in Figure 7, which shows two ways in which
better position to interact with macromolecular ligands.the bent form might be related to the membrane. These
There are currently no data available to distinguish be-differ in the orientation of the membrane-proximal
tween these two possibilities.“ankles” of the legs relative to the membrane; this is of
Thus, the preponderance of the evidence strongly fa-course unknown at present. In the switch-blade (Beg-
vors models in which activation of the ligand bindinglova et al. 2002; Shimaoka et al., 2002) or “flick-knife”
domain in the head and binding of ligand are coupled,(Liddington, 2002) model, the “calves” of each leg are
via long-range conformational changes in the legsperpendicular to the membrane and the head domain
(probably including straightening and separation), tois very close to the cell surface. In a variant “angle-
separation of the bases of the legs and the attachedpoise” model, the legs are bent over closer to the mem-
brane and extend like an angle-poise lamp during activa- transmembrane and cytoplasmic domains. This cou-
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pling is bidirectional and reciprocal and is best viewed Open Questions and Future Directions
Although the models presented (Figures 5–7) are consis-in terms of an allosteric equilibrium, or series of equilibria
tent with a broad range of data, including the 3D struc-(Figure 7). Binding of extracellular ligand would therefore
tures, they remain working hypotheses and require ex-enhance separation of the cytoplasmic domains,
perimental tests. Foremost among these is the pressingallowing their interaction with cytoskeletal and signal
need for integrin/ligand cocrystals to investigate thetransduction molecules, that is, outside-in signaling
conformation of ligand bound integrins. Does an acti-(Figure 2). Reciprocally, separation of the cytoplasmic
vated integrin actually stand up as implied by Figuresdomains by talin and perhaps other activators would
4B and 7? Do the legs separate? What exactly are theactivate the head for ligand binding, that is, inside-out
conformational changes in the -I/A domain and thesignaling (Figure 6). The distinction between these two
domains in the legs? Much immunological evidenceforms of integrin signaling has been conceptually useful
demonstrates the existence of conformational changesover the past decade, but they should actually be viewed
in these domains, but what exactly are they? In fact, weas two reflections of the same allosteric equilibrium.
lack any definitive structures for the PSI domain andEither cytoplasmic or extracellular interactions can trap
several of the I-EGF domains. There are inconsistenciesthe equilibrium in the active state, enhancing thereby
between the disulfide bonding patterns for I-EGF-3 de-the function at the opposite end of the integrin. One
duced from the X-ray crystallography (Xiong et al., 2001)could also imagine cytoplasmic interactors that could
and by NMR (Beglova et al., 2002). Could these perhapstrap the equilibrium in the inactive state, stabilizing the
reflect possible disulfide interchanges within the integ-integrin in the “off” state as on resting platelets or leuko-
rin, as has been suggested (Yan and Smith, 2000, 2001;cytes. Similarly, antibodies that activate integrins or rec-
O’Neill et al., 2000)? What is the significance of the otherognize only the active state presumably trap the equilib-
divalent cations bound to integrins? Does the -I/A do-rium in the active state, and some function-blocking
main change conformation in the same way as the -I/Aantibodies are also known to act allosterically rather
domain? Does its C-terminal helix move down, alteringthan at the actual ligand binding site and presumably
the relationship between the -I/A and hybrid domains?act by trapping the equilibrium in the inactive state; I
Does the -I/A domain rotate away from the propeller,will discuss an example of this below.
opening up the top of the integrin for more extensiveFigure 7 depicts an integrin lacking an -I/A domain.
interactions with macromolecular ligands? Are there in-We need to consider how the situation might differ for
termediate, stable conformers and different activationthose integrins with an inserted -I/A domain. In these
states, as suggested by some data? Do all integrinsintegrins, ligand is wholly or largely bound by the -I/A
undergo extreme changes in conformation or are somedomain. As discussed earlier, recombinant -I/A do-
more subtle in their approach? Is there linkage betweenmains can bind ligand with the same affinity and speci-
-I/A and -I/A domains as suggested in Figure 5B?ficity as intact integrins, especially when locked in the
Why do some integrins have -I/A domains, anyway?active conformation. Many inactivating mutations and
Although the current data favor the model that theepitopes for function-blocking antibodies lie in the -I/A
inactive state of integrins is a bent form as seen in thedomains and deletion of these domains inactivates the
X-ray structure (or something very like it), this requiresintegrins. As discussed above, the active conformation
further investigation and its generality needs testing. Theof -I/A domains shows a downward shift of the C-ter-
results of Takagi et al. (2002) clearly show that soluble3minal helix (Figure 3). This could clearly propagate a
integrins and those on the cell surface do adopt a bent,conformational change to other domains of the integrin.
inactive form, which can be induced to extend by appro-Alonso et al. (2002) have suggested that a highly con-
priate manipulations, However, it would be helpful to beserved glutamate just C-terminal to the C-terminal helix
able to monitor this process in living cells, perhaps usingcould act as a pseudoligand for the -I/A MIDAS site,
conformation-specific antibodies or FRET. We also do
acting as a ligand relay (Figure 5B). They present muta-
not know exactly how the bent extracellular part of an
genesis data in support of this model, although it, like
integrin is connected to the membrane. What is the
all the other models discussed here, will need further significance of the fact that most integrins lacking an
confirmation. Consistent with the model is the fact that
-I/A domain are cleaved near the base of their  subunit
there exist both mutations in, and function-blocking an- legs (in the calf2 domain), whereas none of those with
tibodies against, the -I/A domain that preclude binding an -I/A domain is so cleaved? We know essentially
of ligand at the -I/A domain unless the -I/A domain nothing about the transmembrane domain structures
is locked in the open position when it becomes immune and their interactions. They are always assumed to be
to such inhibition (Lu et al., 2001c). Based on these and helical but are they and, if so, how long are they? The
other results, Shimaoka et al. (2002) proposed that the results of Armulik et al. (1999) suggest that the TM seg-
-I/A domain is activated by allosteric interactions with ments may be longer than necessary for a straight, per-
the -I/A domain and proposed that the C-terminal helix pendicular  helix and could even move in and out of
acts like a bell rope to open the -I/A domain. This is the membrane to some degree. There are intriguing con-
entirely compatible with the ligand-relay model (Figure servations in primary sequence among integrin TM do-
5). Thus, it appears likely that integrins containing -I/A mains; what do they mean? Do the  and  TM segments
domains function in essentially the same way as those interact? Do other integral membrane proteins known
which lack that extra domain, differing only in that there to interact with integrins perhaps interact within the
is an extra step in the chain of linked conformational membrane? Could this affect activation and signaling?
changes connecting the ligand binding site with the cy- Possible candidates for such interactions and effects
include IAP/CD47 (Brown and Frazier, 2001), tetraspa-toplasmic domains.
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nins (Hemler, 2001), CD98 (Fenczik et al., 1997; Kolesni- tors will continue in the next few years as these ques-
kova et al., 2001), and others (Hemler, 1998; Hughes tions and others are addressed, incorporating structural
and Pfaff, 1998), importantly including the growth factor information along with the cell biological data and new
receptors with which integrins cooperate in signal trans- techniques such as proteomic analysis of complexes
duction (Figure 2). and real-time imaging of molecules and their interac-
The role of cytoplasmic domain separation in integrin tions in situ. One hope is that the insights obtained will
signaling seems well established, but we need to know lead to better therapeutic agents targeting integrins in
more about exactly what happens. What are the precise human diseases as diverse as thrombosis, hemorrhage,
structures of the cytoplasmic domains in the inactive inflammation, atherosclerosis, osteoporosis, cancer,
and active states? If the talin head PTB domain binds and infectious diseases. It is, after all, the biological
 tails and activates integrins, as seems clear, do other importance of these receptors that makes them particu-
proteins with PTB domains do the same or do some of larly interesting; the elegance of their allosteric signal
those proteins only bind a previously activated tail? Do transduction mechanisms is an extra bonus.
some such proteins prefer a phosphorylated NPxY se-
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